Found 36 matching trials
Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants PHASE3 Study Hypothesis: Preterm infants administered weekly Darbe during the neon...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Darbepoetin Alfa in Patients With Anemic Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) PHASE3 The primary objective was to assess the superiority of darbepoetin alfa ver...
Show More Learn More & Join Trial
Heart Failure and Anemia PHASE2 The purpose of this study is to determine whether increasing hemoglobin con...
Show More Location
Multiple Locations
Learn More & Join Trial
Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of Cancer PHASE2 The purpose of this trial is to demonstrate benefit with respect to hematop...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa PHASE3 The purpose of this study is to evaluate whether increasing or maintaining ...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluation of Monthly Darbepoetin Alfa Dosing for Correction of Anemia in Non-dialysis Chronic Kidney Disease PHASE3 The purpose of this study is to determine whether once monthly (QM) dosing ...
Show More Learn More & Join Trial
Subcutaneous (SC) Darbepoetin Alfa in Subjects With Symptomatic Congestive Heart Failure (CHF) & Anemia PHASE2 The purpose of this study is to evaluate whether weight-based or fixed star...
Show More Location
Multiple Locations
Learn More & Join Trial
Darbepoetin for Ischemic Neonatal Stroke to Augment Regeneration PHASE2 The aim of the study is to perform a randomized double-blind placebo contro...
Show More Location
Wilhelmina Childrens Hostpital/University Medical Center Utrecht
Learn More & Join Trial
Darbepoetin Administration to Preterm Infants PHASE2 Infants born prematurely do not increase production of the primary red cell...
Show More Location
University of Colorado
Learn More & Join Trial
Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan PHASE3 For hemodialysis subjects currently receiving ESAs with anemia associated w...
Show More Learn More & Join Trial